These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21210479)

  • 1. Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling.
    Akolekar R; Bower S; Flack N; Bilardo CM; Nicolaides KH
    Prenat Diagn; 2011 Jan; 31(1):38-45. PubMed ID: 21210479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal loss after chorionic villus sampling in twin pregnancy.
    Elger T; Akolekar R; Syngelaki A; De Paco Matallana C; Molina FS; Gallardo Arozena M; Chaveeva P; Persico N; Accurti V; Kagan KO; Prodan N; Cruz J; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jul; 58(1):48-55. PubMed ID: 34038977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis.
    Beta J; Zhang W; Geris S; Kostiv V; Akolekar R
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):452-457. PubMed ID: 30977213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.
    Wulff CB; Gerds TA; Rode L; Ekelund CK; Petersen OB; Tabor A;
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):38-44. PubMed ID: 26581188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedure-Related Fetal Loss following Chorionic Villus Sampling after First-Trimester Aneuploidy Screening.
    Wah YM; Leung TY; Cheng YKY; Sahota DS
    Fetal Diagn Ther; 2017; 41(3):184-190. PubMed ID: 27399158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and risks associated with screening for chromosomal abnormalities during pregnancy.
    Dhaifalah I; Zapletalova J
    Ceska Gynekol; 2012 Jun; 77(3):236-41. PubMed ID: 22779726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chorionic villus sampling: 10 years of experience in a University referral center.
    Martins AT; Francisco C; Correia H; Cohen Á
    J Gynecol Obstet Hum Reprod; 2020 May; 49(5):101715. PubMed ID: 32084611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approach for estimating risk of miscarriage after chorionic villus sampling.
    Gil MM; Molina FS; Rodríguez-Fernández M; Delgado JL; Carrillo MP; Jani J; Plasencia W; Stratieva V; Maíz N; Carretero P; Lismonde A; Chaveeva P; Burgos J; Santacruz B; Zamora J; De Paco Matallana C
    Ultrasound Obstet Gynecol; 2020 Nov; 56(5):656-663. PubMed ID: 32281125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks.
    Mastrodima S; Akolekar R; Yerlikaya G; Tzelepis T; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):613-617. PubMed ID: 27561595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
    Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
    Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
    Maiz N; Valencia C; Emmanuel EE; Staboulidou I; Nicolaides KH
    Obstet Gynecol; 2008 Sep; 112(3):598-605. PubMed ID: 18757658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis.
    Salomon LJ; Sotiriadis A; Wulff CB; Odibo A; Akolekar R
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):442-451. PubMed ID: 31124209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of stillbirth from placental growth factor at 11-13 weeks.
    Akolekar R; Machuca M; Mendes M; Paschos V; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):618-623. PubMed ID: 27854388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the rate and risk factors for fetal loss after chorionic villus sampling.
    Odibo AO; Dicke JM; Gray DL; Oberle B; Stamilio DM; Macones GA; Crane JP
    Obstet Gynecol; 2008 Oct; 112(4):813-9. PubMed ID: 18827123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
    Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH
    BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.
    Akolekar R; Beta J; Picciarelli G; Ogilvie C; D'Antonio F
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):16-26. PubMed ID: 25042845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study.
    Tabor A; Vestergaard CH; Lidegaard Ø
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):19-24. PubMed ID: 19504504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.